An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...
Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...
Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.
A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing Charles River's immunology expertise to refine study ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback